Toward an Understanding of the Physiological Function of Mammalian Stem Cells  by Joseph, Nancy M. & Morrison, Sean J.
Developmental Cell, Vol. 9, 173–183, August, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.devcel.2005.07.001
ReviewToward an Understanding of the
Physiological Function of Mammalian Stem CellsNancy M. Joseph and Sean J. Morrison*
Howard Hughes Medical Institute and
Departments of Internal Medicine and
Cell and Developmental Biology
1500 East Medical Center Drive
University of Michigan
Ann Arbor, Michigan 48109
Summary
Stem cell biology has the potential to yield new thera-
pies, new insights into disease, and a clearer under-
standing of tissue formation and maintenance. How-
ever, much of what we know about many stem cells
is based upon experiments performed in culture.
Stem cells sometimes exhibit critical differences in
their properties or regulation between the culture and
in vivo environments. Though cell lines with stem cell
properties can be derived from the long-term culture
of diverse tissues, it is not clear whether cells with
similar properties exist in vivo. If the goal is to use
differentiated cells for therapy or drug screening, it
may not matter whether these stem cells exist in vivo.
However, to understand tissue development/mainte-
nance or the role of stem cells in disease, it is impor-
tant to characterize progenitor function in vivo to
evaluate physiological significance.
Stem cells are capable of self-renewal and the genera-
tion of large numbers of differentiated progeny, often
including multiple types of progeny. Beyond these cri-
teria, stem cells distinguish themselves from other pro-
genitors by having the broadest developmental poten-
tial in a particular tissue at a particular time. Different
types of stem cells have different developmental poten-
tials, including pluripotent embryonic stem cells that
can generate every cell type in the body and multipo-
tent stem cells, such as hematopoietic stem cells, that
generate diverse cells in a particular tissue but gen-
erally lack the ability to make cells in other tissues.
Some stem cells, like hematopoietic stem cells, have
been extensively studied in vivo, and their physiological
function is well characterized. Other stem cells, like
embryonic stem cells, have been derived in culture and
have properties that differ from the blastocyst inner cell
mass from which they arise (Nichols et al., 2001). Al-
though embryonic stem cells are a culture “artifact” in
the sense that they acquire certain properties that are
not exhibited in a blastocyst, they remain capable of
generating functionally normal cells in all tissues (Nagy
et al., 1993).
The fact that stem cells sometimes acquire unphysio-
logical but potentially therapeutically useful properties
in culture creates a tension. On the one hand, we study
stem cells partly to understand their role in develop-
ment and disease. For these aims, it is critical to under-*Correspondence: seanjm@umich.edustand where and when stem cells are actually present
in vivo, what they are actually doing, and how these
physiological functions are regulated. On the other
hand, if the goal is to generate differentiated cells for
drug screening, toxicity screening, or even for certain
cell therapies, then it may not matter whether the stem
cells that form the differentiated cells have acquired
some of their properties in culture.
The lines between these divergent aims are not al-
ways clear. Recent evidence indicates that it is possible
to derive cell lines with compelling stem cell properties
from the long-term culture of adult tissues that do not
necessarily exhibit similar properties in vivo (Pittenger
et al., 1999; Jiang et al., 2002; Li et al., 2003; Zhao et
al., 2003; Kanatsu-Shinohara et al., 2004; Kogler et al.,
2004). Do these cell lines reflect previously unappreci-
ated but physiologically important stem cells that are
active in vivo, or do they reflect cells that lack stem
cell properties in vivo and acquire such properties by
reprogramming in culture? If these cells acquire un-
physiological properties in culture, will they represent
stable sources of differentiated cells that are normal
enough to be therapeutically useful?
To navigate these complex questions, it is important
to clearly recognize what we know and what we don’t.
In the words of Yogi Berra, “You can observe a lot just
by watching” but “You’ve got to be very careful if you
don’t know where you’re going, because you might not
get there.” Yogi’s meaning shines through the internal
ambiguities and inconsistencies in his words, just as
the promise of stem cell research is not dulled by its
inherent ambiguities and inconsistencies. Nonetheless,
we are much more likely to get where we want to go if
we are thoughtful about potential disconnects between
physiological function and therapeutic utility.
The Disconnect between Developmental Potential
in Culture and In Vivo
There are several well-documented examples of pro-
genitors that broaden their developmental potential in
culture in ways that do not appear to occur under phys-
iological circumstances (Figure 1). During normal devel-
opment, primordial germ cells give rise primarily or ex-
clusively to germ cells and their progenitors (Wei and
Mahowald, 1994). When primordial germ cells are in-
jected into blastocysts, they do not detectably contrib-
ute to developing embryonic tissues, suggesting that
they are committed under physiological circumstances
to the germline lineage (Donovan, 1994). However, if
these cells are cultured for 6 days in the presence of
steel factor, fibroblast growth factor, and leukemia in-
hibitory factor, they form colonies with characteristics
of embryonic stem cells and early passage lines de-
rived from these colonies contribute to all tissues upon
injection into blastocysts (Matsui et al., 1992; Donovan,
1994). This demonstrates that primordial germ cells can
be quickly reprogrammed in culture to exhibit a broader
developmental potential.
Postnatal somatic progenitors can also be repro-
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174Figure 1. Cell Culture Changes the Developmental Potential and Fates of Progenitor Cells
(A) After culture, both primordial germ cell (PGC) lines and multipotent adult progenitor cell (MAPC) lines from adult bone marrow undergo
pluripotent differentiation upon transplantation into blastocysts (Matsui et al., 1992; Donovan, 1994; Jiang et al., 2002). However, uncultured
PGCs do not engraft in blastocysts, suggesting that cell culture dramatically changes their developmental potential (Donovan, 1994). The
developmental potential of uncultured MAPCs has not yet been tested because these cells have not been prospectively identified.
(B) Cell culture can also change the fates that progenitors acquire. Oligodendrocyte precursor cells (OPCs) as well as Olig2+ and Olig2−
progenitors from the developing neural tube all give rise to neurons, oligodendrocytes, and astrocytes in cell culture despite the fact that
these progenitors do not appear to undergo multilineage differentiation in vivo (Kondo and Raff, 2000; Gabay et al., 2003). In each case, these
cells undergo changes in culture that are associated with the broadening of the fates they acquire.grammed in culture to acquire a broader developmental r
dpotential. Oligodendrocyte precursor cells have been
extensively studied by many laboratories and are
ithought to form only glia in vivo. When these cells are
purified from rat optic nerves based on surface-marker b
rexpression, they form colonies in culture that contain
only oligodendrocytes or oligodendrocytes and astro- t
gcytes. However, if these cells are sequentially cultured
in the presence of bone morphogenetic proteins c
t(BMPs) and then fibroblast growth factor (FGF), they
give rise to multipotent neurospheres capable of form- o
ging neurons, astrocytes, and oligodendrocytes (Kondo
and Raff, 2000). The neurogenic cells did not represent Z
ga contaminating-cell population because the starting
cells were more than 99% pure for restricted oligoden- d
Odrocyte progenitors. Yet most of these cells survived
and proliferated in response to BMPs and FGF, acquir- t
ting the ability to make neurons. These results suggest
that diverse progenitors can acquire a broader develop- (
bmental potential in culture.
Is it safe to conclude that cells that undergo multilin- a
geage differentiation in culture actually undergo multilin-
eage differentiation in vivo? Cells from the neural tube t
tundergo multilineage differentiation in culture, suggest-
ing that this population gives rise to the neurons, t
sastrocytes, and oligodendrocytes that comprise the
spinal cord (Kalyani et al., 1997). However, fate-map-
rping studies have found that progenitors in different re-
gions of the neural tube are patterned by morphogen t
pgradients to express different genes and to ultimately
adopt different fates (Jessell, 2000) (Figure 2B). This t
isuggests that different types of mature cells in the spi-
nal cord arise from different progenitor pools in the neu- wal tube, rather than from common stem cells that un-
ergo multilineage differentiation.
To address this issue, Anderson and colleagues have
solated progenitors from the developing neural tube
ased on their expression of transcription factors that
egulate fate determination and compared the differen-
iation of these progenitors in vivo and in culture. Pro-
enitors that generate motor neurons and oligodendro-
ytes are located in the ventral neural tube and express
he Olig1 and Olig2 transcription factors that regulate
ligodendrocyte and motor-neuron development (Mizu-
uchi et al., 2001; Novitch et al., 2001; Lu et al., 2002;
hou and Anderson, 2002) (Figure 2B). Progenitors that
enerate interneurons and astrocytes are located in the
orsal neural tube and generally do not express the
lig genes. But when sorted into culture, both the ven-
ral Olig2+ progenitors and the dorsal Olig2− progeni-
ors formed neurons, astrocytes, and oligodendrocytes
Gabay et al., 2003). In culture, some Olig2− progenitors
egin to express Olig2 (presumably explaining their
bility to form oligodendrocytes), and some Olig2+ pro-
enitors lose Olig2 expression (presumably explaining
heir ability to form astrocytes). These results suggest
hat the patterning of progenitors can be altered in cul-
ure, leading to the acquisition of fates that are not ob-
erved under physiological conditions.
One possibility is that neural-tube progenitors simply
etain a broader developmental potential than they ac-
ually exhibit in vivo and are able to exhibit this broader
otential in culture. Alternatively, the developmental po-
ential of neural tube progenitors may be reprogrammed
n culture. To distinguish between these possibilities, it
ould be necessary to transplant Olig2− dorsal progen-
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175Figure 2. Studies Performed In Vivo Indicate that Multipotent Stem
Cells from Different Tissues Employ Different Strategies for the
Generation of Diversity
(A) There are differences in hematopoiesis between the fetal liver
and fetal spleen, but there are no intrinsic differences between the
stem cells from these tissues. This means that spatial differences
in hematopoiesis are determined by environmental differences be-
tween hematopoietic tissues, not by intrinsic differences between
the stem cells (Kiel et al., 2005a).
(B) In the developing spinal cord, progenitors are patterned by mor-
phogen gradients from the floor plate (FP) and roof plate (RP). At
each level along the dorsoventral axis, these morphogen gradients
pattern neural progenitors to acquire intrinsically different proper-
ties that determine the fates they acquire (Jessell, 2000). For exam-
ple, progenitors in the ventral pMN domain express Olig1 and Olig2important and necessary, parallel studies in vivo are
transcription factors that promote oligodendrocyte and motorneu-
ron differentiation, whereas most progenitors in the dorsal neural
tube do not express Olig genes and generate astrocytes and inter-
neurons. This panel was adapted from (Anderson, 2001).
(C) Neural-crest stem cells isolated from the developing gut and
nerve display intrinsic differences in their sensitivity to lineage de-
termination factors that cause these multipotent stem cells to
sometimes acquire different fates, even when transplanted into the
same in vivo environment (Bixby et al., 2002). These results demon-
strate that the nervous system employs a fundamentally different
strategy than the hematopoietic system when it comes to generat-
ing diversity from stem cells: although hematopoietic stem cells
avoid regional differences in their cell-intrinsic properties, neural
stem cells are patterned to acquire distinct regional identities (Ma-
latesta et al., 2003).itors into the ventral neural tube to determine whether
these cells retain the ability to express Olig2 or to form
oligodendrocytes and motor neurons in vivo. Unfortu-
nately, this experiment is extremely technically difficult.
Interestingly, however, recent studies have indicated
that some dorsal progenitors can express Olig2 and
form oligodendrocytes (Cai et al., 2005; Vallstedt et al.,
2005). These observations suggest that at least some
Olig2− dorsal progenitors retain the potential to express
Olig2 and to form oligodendrocytes in vivo, though it
remains possible that the Olig2+ and Olig2− dorsal pro-
genitors arise from distinct lineages. Additional experi-
ments will be required to fully understand the signifi-
cance of these observations. Nonetheless, these results
raise the question of whether progenitors from other
regions of the central nervous system (CNS) that un-
dergo multilineage differentiation in culture actually
form neurons, astrocytes, and oligodendrocytes in vivo.
Significant differences have also been observed in
the differentiation of neural-crest stem cells in culture
and in vivo (Figure 3). Individual neural-crest stem cells
isolated from developing nerves readily form sym-
pathoadrenal neurons in culture (Morrison et al., 2000).
However, when uncultured neural-crest stem cells are
injected into chick embryos, they migrate into de-
veloping sympathetic ganglia and form neurons, but
the neurons rarely express sympathoadrenal markers
(White et al., 2001). High levels of BMP stimulation ap-
pears necessary for neural-crest stem cells to acquire
a sympathoadrenal phenotype, and the failure to fully
differentiate into sympathoadrenal neurons in vivo cor-
relates with a reduced sensitivity to BMP stimulation in
nerve neural-crest stem cells (Shah et al., 1996; Schnei-
der et al., 1999; White et al., 2001). This suggests that
nerve neural-crest stem cells more readily acquire a
sympathoadrenal fate in culture because it is possible
to stimulate these cells with super-physiological levels
of BMPs in culture. Because temporal and spatial dif-
ferences in the sensitivity of neural stem cells to lin-
eage-determination factors represent major mecha-
nisms by which the differentiation of multipotent cells
is regulated in vivo (White et al., 2001; Bixby et al., 2002;
Kruger et al., 2002) (Figure 2C), neural stem cells may
often acquire certain fates more readily in culture where
high concentrations of growth factors can overcome
their reduced sensitivity to certain signals.
Although studies of stem cell function in culture are
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176Figure 3. Nerve Neural-Crest Stem Cells
Readily Differentiate into Sympathoadrenal
Neurons in Culture but Only Rarely Do So
In Vivo
Postmigratory neural-crest stem cells can be
isolated by flow cytometry from developing
peripheral nerves (Morrison et al., 1999). In
culture, virtually every stem cell from this
population is able to form thousands of sym-
pathoadrenal neurons in clonal assays (Mor-
rison et al., 2000). (A) to (C) show a single
field of view from a typical neural-crest stem
cell colony (which arose from a single cell)
including a subset of neurons (neurofila-
ment, green) that colabel with the sympatho-
adrenal marker tyrosine hydroxylase (TH,
red). (D) to (F) show sections through the
aortic plexus of stage 29 chick embryos that
were injected with uncultured rat nerve neu-
ral-crest stem cells isolated by flow cyto-
metry. A subset of these cells expressed the
rat neuronal marker SCG10 (D), the rat sympathetic markers GATA-2 (E), and tyrosine hydroxylase (F) (White et al., 2001). Although the rat
neural-crest stem cells often migrated to chick sympathetic ganglia, this was the only example of overt sympathoadrenal differentiation out
of 51 chicks analyzed. This demonstrates that these nerve neural-crest stem cells are able to acquire a sympathoadrenal fate in vivo but
much less efficiently than in culture. Such differences in the efficiency with which certain fates are acquired may be common, given that stem
cells are routinely stimulated with super-physiological concentrations of growth factors in culture. It will likely be important to take this
phenomenon into account in any cell therapy in which undifferentiated cells from a solid tissue are transplanted in vivo. This figure was
generated with previously published images (Morrison et al., 2000; White et al., 2001).helpful to evaluate the physiological significance of P
owhat is observed in culture. When cells are removed
from the morphogen gradients in which they reside o
iin vivo and placed in unphysiological culture environ-
ments, the patterning of these cells is changed (Ander- f
ison, 2001). The dissociation of cells also disrupts the
normal cell-cell interactions that stem cells have in vivo, o
rand these highly regulated interactions in vivo are rarely
re-established in culture. Stem cells in culture thus ex- r
2perience the loss of some signals as well as exposure
to new signals or unphysiologically high levels of those
signals. Either way, this leads to changes in the expres-
sion of genes that regulate cell cycle, developmental po-
tential, and fate determination. By understanding the
ways in which cells change their properties in culture,
results can be interpreted more clearly, distinguishing
between physiological and nonphysiological properties.
The Disconnect between Stem Cell Self-Renewal
in Culture and In Vivo
A variety of mechanisms that have been implicated in
the regulation of stem cell self-renewal exhibit impor-
tant differences when compared between the in vitro
and in vivo environments (Figure 4). Wnt pathway acti-
vation is necessary and sufficient for the promotion of
adult hematopoietic stem cell self-renewal in culture
(Murdoch et al., 2003; Reya et al., 2003; Willert et al.,
2003). However, conditional deletion of b-catenin from
adult hematopoietic stem cells in vivo does not appear F
Sto cause a self-renewal defect (Cobas et al., 2004). It
remains unknown whether the Wnt pathway operates W
edifferently in culture or whether there are redundant sig-
anals in the more complex in vivo environment. In cul-
sture, Bmi-1 is necessary for the self-renewal of diverse
2
types of fetal and postnatal stem cells, but in vivo Bmi-1 f
appears necessary for the self-renewal of postnatal B
sstem cells but not fetal stem cells (Molofsky et al., 2003;003, 2005). Because multiple self-renewal pathways
igure 4. Pathways that Are Necessary and Sufficient for Stem Cell
elf-Renewal in Culture Are Not Always Necessary In Vivo
nt pathway activation is necessary and sufficient for hematopoi-
tic stem cell self-renewal in culture (Reya et al., 2003; Willert et
l., 2003), but conditional deletion of b-catenin has not been ob-
erved to deplete hematopoietic stem cells in vivo (Cobas et al.,
004). Similarly, Bmi-1 is necessary for the self-renewal of both
etal and adult neural stem cells (NSC) in culture. However, in vivo,
mi-1 is only necessary for the self-renewal of adult NSCs (Molof-
ky et al., 2003, 2005).ark et al., 2003). This appears to be explained by the
bservation that Bmi-1 is necessary for the repression
f the Ink4a tumor suppressor in postnatal stem cells
n vitro and in vivo, but although Ink4a is induced in
etal neural stem cells in culture, Ink4a is not expressed
n vivo during fetal development, even in the absence
f Bmi-1 (Molofsky et al., 2003; Park et al., 2003). As a
esult, fetal neural stem cells exhibit a profound self-
enewal defect in culture but not in vivo (Molofsky et al.,
Reviews
177converge by regulating Ink4a expression (Ito et al.,
2004; Passegue et al., 2004) and Ink4a is induced in
many cells in response to stress in culture (Sherr, 2001),
this change in Ink4a regulation likely imposes unphysi-
ological constraints on stem cell self-renewal in culture.
These changes in developmental potential and in the
regulation of self-renewal in culture are not isolated, as
many stem cell properties change in culture. Long-term
culture of neural stem cells leads to increasing irregu-
larities in the properties of these cells, including ongo-
ing changes in gene expression, adhesion properties,
and growth-factor dependence (Morshead et al., 2002).
The cell-cycle regulation of adult stem cells also
changes in culture because these cells are typically
quiescent in vivo (Morshead et al., 1994; Cheshier et
al., 1999) but are driven into cycle in most culture condi-
tions. Stem cell gene expression profiles likely change
extensively as the cells adapt to culture conditions.
This may impair our ability to identify physiological reg-
ulators of stem cell function when hypotheses are
based on the gene-expression profiles of cultured cells.
This is also likely to be a confounding factor in studies
that compare the gene-expression profiles of different
stem cell populations, some of which are expanded in
culture and some of which are not (Terskikh et al., 2001;
Ivanova et al., 2002; Ramalho-Santos et al., 2002).
Studying Stem Cells In Vivo
Our understanding of hematopoietic stem cell function
was dramatically advanced by the ability to identify and
purify these cells based on the surface markers they
express (Spangrude et al., 1988; Morrison and Weiss-
man, 1994). When it became possible to reliably predict
which cells were stem cells and which cells were not,
based on surface-marker expression, it became pos-
sible to directly study their cell-cycle status (Morrison
and Weissman, 1994; Cheshier et al., 1999), their rela-
tionship to other hematopoietic progenitors in vivo
(Kondo et al., 1997; Morrison et al., 1997; Akashi et al.,
2000; Adolfsson et al., 2005), and the genes they ex-
press (Phillips et al., 2000; Ivanova et al., 2002; Ra-
malho-Santos et al., 2002; Kiel et al., 2005b). Without
the ability to purify hematopoietic stem cells based on
marker expression, none of these insights would have
been possible.
It is sometimes considered impractical to study stem
cells from solid tissues with the approaches pioneered
in the hematopoietic system because stem cell viability
declines with tissue dissociation/flow cytometry, or
stem cell markers/in vivo assays do not exist. However,
methods can be developed to prospectively identify
and study stem cells from solid tissues in vivo. One
example comes from the neural crest. During midgesta-
tion, neural-crest cells migrate out of the neural tube
and give rise to the neurons and glia that compose the
peripheral nervous system, as well as melanocytes and
some types of mesectodermal cells (Le Douarin, 1986).
Most neural-crest cells that migrate out of the neural
tube are multipotent in clonal assays in culture (Sieber-
Blum and Cohen, 1980; Baroffio et al., 1988; Stemple
and Anderson, 1992). Consistent with this, fate-map-
ping experiments in which individual neural-crest cells
were labeled in vivo showed that many neural-crestcells actually undergo multilineage differentiation, form-
ing variable combinations of neurons and nonneuronal
cells (Bronner-Fraser and Fraser, 1988, 1989; Fraser and
Bronner-Fraser, 1991). For example, 45% of individual
avian neural-crest cells labeled prior to the onset of mi-
gration gave rise to at least two neural-crest deriva-
tives, and 20% of cells contributed to at least three de-
rivatives (Bronner-Fraser and Fraser, 1989).
Like hematopoietic stem cells, neural-crest stem
cells can be prospectively identified and isolated by
flow cytometry based on their expression of p75 and
other markers (Morrison et al., 1999; Bixby et al., 2002;
Kruger et al., 2002), making it possible to compare their
properties in vivo and in culture. Most of the single cells
from within these prospectively identified populations
self-renew and undergo multilineage differentiation in
culture, forming neurons, glia, and myofibroblasts (Stem-
ple and Anderson, 1992; Shah et al., 1994, 1996; Morrison
et al., 1999). Consistent with this, freshly isolated neu-
ral-crest stem cell populations also give rise to diverse
types of neurons and glia upon injection into the neural-
crest migration pathway of chick embryos (Morrison et
al., 1999; White and Anderson, 1999; White et al., 2001;
Bixby et al., 2002; Kruger et al., 2002). This demon-
strates that these cells have the potential to migrate
long distances in the developing peripheral nervous
system and to form diverse derivatives in vivo, though
it has not been technically possible to examine the dif-
ferentiation of single transplanted cells in vivo.
Studies of stem cell function in vivo can change the
way we understand neural development. Neural-crest
stem cells persist throughout late gestation in de-
veloping peripheral nerves (Morrison et al., 1999; Bixby
et al., 2002). Based on Cre-recombinase fate mapping,
these neural-crest stem cells appear to undergo multi-
lineage differentiation in developing nerves, generating
nerve fibroblasts in addition to myelinating and nonmy-
elinating Schwann cells (Joseph et al., 2004). These re-
sults demonstrate that neural-crest cells play a more
dynamic role in nerve development than previously ap-
preciated. Moreover, the observation that trunk neural-
crest stem cells give rise to nerve fibroblasts in vivo
demonstrates that their ability to form myofibroblasts
in culture is not an artifact of culture but rather reflects
a fate that these cells actually acquire in vivo (Joseph
et al., 2004). This is an example of how experiments
performed in culture can reveal unanticipated aspects
of stem cell function in vivo and can lead to important
new insights into development. Other recent fate-map-
ping studies have revealed similarly informative results,
suggesting that boundary cap cells that mark the entry/
exit points of peripheral nerves to/from the neural tube
are themselves progenitor cells that contribute neurons
and glia to developing sensory ganglia (Maro et al.,
2004). Experience with neural crest shows that viable
stem cells can be isolated from solid tissues, that mark-
ers for these cells can be identified, and that the func-
tion of these cells can be studied in vivo.
Physiological Roles for Stem Cells
in Tissue Maintenance
Stem cells are acutely required for the maintenance of
many but not all mammalian tissues throughout adult
Developmental Cell
178life. Hematopoietic stem cells give rise to many types o
of blood cells that must be replaced on a daily basis d
throughout life. Mutations in a variety of pathways that m
lead to the depletion of hematopoietic stem cells cause i
hematopoietic failure and death (Park et al., 2003; Hock w
et al., 2004a, 2004b; Ito et al., 2004). Gut epithelial stem (
cells replace all lineages of gut epithelial cells that regu- e
larly turnover in the adult gut (Potten and Loeffler, 1990; t
Batlle et al., 2002). Loss of Tcf-4 abolishes Wnt signal- i
ing in gut epithelial stem cells, leading to their depletion l
and the death of mice shortly after birth with abnormal q
small intestines (Korinek et al., 1998). Interfollicular epi- (
dermis contains keratinocyte stem cells that give rise a
to the keratinocytes that form skin and turn over e
throughout adult life (Jones et al., 1995; Watt, 2001). t
Overexpression of c-myc in epidermal stem cells leads t
to their premature differentiation and depletion, causing f
skin ulcers to develop and severely impairing wound t
healing (Arnold and Watt, 2001; Waikel et al., 2001). In i
each of these cases, genetic manipulations that lead to s
stem cell depletion prevent the regeneration of dif- o
ferentiated cells, leading to a loss of tissue integrity a
and death.
There are numerous other examples of mammalian f
stem cells that are associated with specific physiologi- g
cal roles but in which loss of these cell populations t
does not necessarily lead to death. In rodents, CNS
2
stem cells near the lateral ventricle give rise to new in-
a
terneurons throughout adult life (Doetsch et al., 1999;
aTemple, 2001) that migrate to the olfactory bulb and
oplay a role in the learned ability to discriminate chemi-
tcally similar odors (Gheusi et al., 2000; Rochefort et al.,
s2002). Stem cells in the dentate gyrus of the hippocam-
dpus give rise to new interneurons throughout adult life
u(Palmer et al., 1997; Eriksson et al., 1998; van Praag
tet al., 2002) that may regulate certain types of spatial
wlearning and memory (Shors et al., 2001). Ablation of
pthese cells eliminates neurogenesis from these regions
rof the adult brain (Garcia et al., 2004). Epithelial stem
scells (Oshima et al., 2001; Blanpain et al., 2004) and
gmelanocyte stem cells (Nishimura et al., 2002, 2005) in
ethe bulge of the hair follicle give rise to new epithelial
cells and melanocytes throughout adult life that form
fpigmented hairs. Loss of the melanocyte stem cells
nleads to hair greying (Nishimura et al., 2005). These are
ponly some of the stem cells that are physiologically im-
aportant in maintaining adult mammalian tissues.
tAlthough stem cells have been identified in many tis-
bsues, stem cells are not necessarily required for the
rmaintenance of adult tissues. Most of the regenerative
acapacity in the adult liver comes from differentiated he-
ppatocytes, which retain tremendous proliferative poten-
mtial (Alison, 1998; Overturf et al., 1999). Similarly, the
tinsulin-secreting β cells in the adult pancreas appear to
farise from other β cells rather than from undifferentiated
ostem cells (Dor et al., 2004). Nonetheless, the fact that
fmost regenerative capacity emerges from the differenti-
iated cells in these tissues under normal circumstances
tdoes not exclude the possibility of facultative stem cell
tpopulations that could engage in tissue repair after cer-
tain types of injury.
a
tThe Uncertain Physiological Significance of Stem
mCell Populations Derived in Culture
tIn addition to the stem cell populations describedabove that have been characterized in vivo, a varietyf cell populations have been derived in culture and
escribed as stem cells based upon properties they
anifest after expansion in culture. The most extens-
vely studied example is mesenchymal stem cells,
hich can be cultured from bone marrow stromal cells
Prockop, 1997). After extensive culture, clonal mes-
nchymal stem cell lines can be derived with the poten-
ial to form bone, cartilage, fat, tendon, and muscle
n vitro and in vivo (Pittenger et al., 1999). However, in
ight of the previous examples of progenitors that ac-
uired a broader developmental potential in culture
see above) (Matsui et al., 1992; Donovan, 1994; Kondo
nd Raff, 2000), a critical question is whether mes-
nchymal stem cells exist as such in vivo or whether
hese cells arise in culture from cells that lack multipo-
ency in vivo. Some have proposed a physiological role
or these cells in the repair of mesenchymal tissues af-
er injury. However, until these cells are prospectively
dentified and shown to form diverse progeny in the ab-
ence of manipulation in culture and to have some type
f physiological progenitor function, it is premature to
scribe any such role to these cells.
It may also be possible to derive pluripotent cells
rom the culture of adult tissues. Multipotent adult pro-
enitor cells (MAPCs) have been derived from the long-
erm culture of bone marrow stromal cells (Jiang et al.,
002). These cells appeared to proliferate indefinitely
nd to differentiate into mesodermal, neuroectodermal,
nd endodermal derivatives in culture. These cells were
bserved to engraft in blastocysts and contribute to all
issues with an efficiency comparable to embryonic
tem cells. However, other laboratories have not yet in-
ependently derived bone marrow cell lines that have
ndergone pluripotent differentiation upon transplanta-
ion into blastocysts. So, it remains to be determined
hether the generation of such cells will be routinely
ossible. If the generation of such cells depends on
eprogramming in culture, it could prove difficult to con-
istently reproduce the conditions required for repro-
ramming. This could yield cell lines with variable prop-
rties that complicate their use.
As with mesenchymal stem cells, the physiological
unction of MAPCs remains unknown because it has
ot yet been possible to isolate the bone marrow cell
opulation that gives rise to MAPCs in culture. Indeed,
variety of laboratories have assigned different names
o the multipotent cells that they have cultured from
one marrow stromal cells because the developmental
elationship between the cells is unclear (Pittenger et
l., 1999; Jiang et al., 2002; Gronthos et al., 2003; D’Ip-
olito et al., 2004). Do these cells derive from a com-
on in vivo progenitor or from different cells, and do
he apparent differences between these cells reflect dif-
erences in the culture conditions used to derive them
r biological differences between the cells they arise
rom? Ongoing efforts by Simmons and colleagues to
solate the uncultured cells from bone marrow that form
hese multipotent cell lines in culture have the potential
o resolve these questions (Gronthos et al., 2003).
These questions regarding the physiological origin
nd significance of stem cell populations derived in cul-
ure are becoming increasingly important as more and
ore cells with surprisingly broad developmental po-
entials are derived. Stem cells with properties that are
similar but not identical to embryonic stem cells, in-
Reviews
179cluding the ability to undergo pluripotent differentiation
after transplantation into blastocysts, have been gener-
ated from the neonatal mouse testis after 1–2 months
in culture (Kanatsu-Shinohara et al., 2004). Other cell
populations that have been described as pluripotent
have been cultured from fetal cord blood (Kogler et al.,
2004) or adult tissues such as inner ear (Li et al., 2003)
and peripheral blood (Zhao et al., 2003). However, these
latter cells have not been shown to contribute to all
tissues after transplantation into blastocysts. Do pluri-
potent stem cells persist throughout many postnatal
tissues, or are a variety of cells from different tissues
capable of acquiring pluripotency after expansion in
culture? Will the phenotypes, developmental potentials,
and karyotypes of these cells be stable in culture? The
answers to these questions are critical to understand-
ing the physiological, developmental, and clinical sig-
nificance of these observations.
Apart from these questions related to physiological
significance, the ability to reprogram cells in culture to
achieve some level of multipotentiality could prove very
useful for the generation of differentiated cells to be
used for compound screening in vitro or even for some
types of cell therapy. Moreover, the generation of such
cells, like the transfer of somatic nuclei into oocytes,
could provide an opportunity to study the reprogram-
ming process. This has the potential to yield fundamen-
tal insights into the regulation of developmental poten-
tial, irrespective of whether such reprogramming ever
occurs under physiological circumstances. Thus ques-
tions regarding the physiological origin of these stem
cell lines derived in culture do not thwart their potential
utility but simply limit our insight into their potential
function in vivo. As with other examples above, we
must proceed with a clear recognition of what we know
and what we don’t.
The Possible Connection between Physiological
Function and Therapeutic Utility
If the goal is purely therapeutic, then does the origin
and physiological significance of cells really matter? In
the context of drug therapies, it depends. By better un-
derstanding the physiological functions of stem cells,
it might be possible to pharmaceutically enhance the
capacity of endogenous stem cells to engage in repair
after injury or disease (Nakatomi et al., 2002). On the
other hand, a major projected application of human em-
bryonic stem cells is in the generation of differentiated
cells for use in drug and toxicity screening in vitro. Al-
though the differentiated cells used in such screens
must be normal enough to give meaningful results, the
origin of the stem cells and their function in vivo may
be irrelevant.
For cell therapies, it depends on whether the stem
cells themselves are transplanted in vivo, or whether
only their differentiated progeny are transplanted. If the
stem cells themselves are transplanted, then it will be
critical to understand their physiological properties
in vivo to ensure that they can not only make appropri-
ate progeny in culture but that they are able to effi-
ciently replace the desired cell types in vivo as well
(without also generating undesirable cell types). If only
differentiated progeny are transplanted, then the ques-
tion is whether those differentiated cells are normal androbust enough to survive transplantation, to integrate
into the tissue, and to function in a way that yields ther-
apeutic benefit.
These issues are being addressed in the context of a
number of diseases, including Parkinson’s disease and
juvenile diabetes, conditions near the top of the list of
major public health problems that could be treated with
stem cell therapies. Replacement of the dopaminergic
neurons lost by Parkinson’s patients or the dopamine
they produce can substantially ameliorate disease
symptoms (Bjorklund and Lindvall, 2000). In Parkin-
son’s patients and animal models, a wide variety of do-
paminergic cells have been tested, including adrenal
chromaffin cells (Watts et al., 1997), glomus cells from
the carotid body (Luquin et al., 1999), fetal ventral mes-
encephalon cells (Studer et al., 1998), and even cell
lines engineered to secrete dopamine (Date et al.,
1996). Of these, only the ventral mesencephalon cells
that give rise to the dopaminergic neurons of the sub-
stantia nigra during fetal development have shown
promising results in patients (Freed et al., 1992; Spen-
cer et al., 1992; Widner et al., 1992). The observation
that the best results were obtained from the physiologi-
cal progenitors of midbrain dopaminergic neurons sug-
gests that for cell therapy to be effective, it is not
enough to be dopaminergic—that functional recovery
depends upon using cells that are physiologically sim-
ilar to the neurons that must be replaced. Nonetheless,
even with ventral mesencephalon cells, survival of the
grafted cells remains low, the cells do not integrate into
their normal circuitry, and these transplants have not
provided a therapeutic benefit to most patients (Freed
et al., 2001; Olanow et al., 2003).
The paucity of human ventral mesencephalon tissue
that is available for grafting has prompted recent
studies to examine dopaminergic neurons generated
from embryonic stem cells (Kawasaki et al., 2000, 2002;
Kim et al., 2002). Dopaminergic neurons differentiated
from mouse or human embryonic stem cells in culture
appear to acquire phenotypes and functional proper-
ties that are similar to mature dopaminergic neurons
in vivo (Kim et al., 2002; Perrier et al., 2004). These cells
have shown promise in rodent (Bjorklund et al., 2002;
Kim et al., 2002) and primate (Takagi et al., 2005) mod-
els of Parkinson’s disease. However, it remains to be
determined whether these neurons that are generated
in culture will adequately survive or integrate after
transplantation to provide a meaningful functional re-
covery without undue side effects.
These issues are likely to be important in other po-
tential stem cell therapies as well (Lindvall et al., 2004).
The transplantation of pancreatic islet cells derived
from organ donors has been effective in the treatment
of juvenile diabetes patients (Shapiro et al., 2000). Al-
though a variety of cultured cell populations exhibit evi-
dence of the ability to generate insulin-secreting cells,
many questions remain about the ability of these cul-
tured cell populations to reverse hyperglycemia in ani-
mal models in vivo (Trucco, 2005). For the replacement
of cell types like neurons or exocrine cells, whose func-
tion must be highly regulated and physiologically ap-
propriate, painstaking work is required prior to trans-
plantation to ensure that these cells not only look
normal in culture but act normally in vivo. On the other
hand, the replacement of tissues that play a primarily
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emuch less subject to detailed considerations regarding
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